{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:12:14Z","timestamp":1789809134103,"version":"4.0.1"},"reference-count":26,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The goal of palliative care is to alleviate the suffering of patients with advanced cancer, such as through pain management. Multiple randomized controlled trials have supported the early integration of palliative care. Despite the undeniable advantages of early palliative care, most data have come from developed countries. This study offers real-life insights into the integration of palliative care services for patients with advanced gastrointestinal cancer and their impact on quality of life in a developing country.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>We retrospectively evaluated patients with metastatic gastrointestinal cancer treated at our center from January 2018 to December 2022. The subjects included patients with metastatic gastrointestinal (GI) cancer who received palliative care either within 90 days of diagnosis (early group) or after 90 days (late group). The impact of early versus late integration of palliative care was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 216 patients were included in the analysis \u2014 123 in the early group and 93 in the late group. While the majority of patients were referred electively to palliative care, emergency referrals were more frequent in the early group (62 total; 40 [64%] in the early group, 22 [36%] in the late group, p = 0.15). The number of patients receiving chemotherapy in the last 30 days of life was 39 (early group: 17; late group: 22; p = 0.06). On the Edmonton Symptom Assessment Scale (ESAS), symptoms such as pain, nausea, and wellbeing were better controlled in the early group, although the differences were not statistically significant. The disease burden was significantly higher in the early group (p = 0.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite a higher disease burden in the early group, symptom control was comparable between the groups. The greater number of emergency referrals in the early group highlights the role of palliative care during crises and underscores the need for better integration of palliative care services.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/jcas-2026-0009","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:31:20Z","timestamp":1789806680000},"page":"59-64","source":"Crossref","is-referenced-by-count":0,"title":["Integrated Palliative care in Metastatic gastrointestinal Cancer: A Retrospective Experience from a Lead Cancer Centre in Pakistan"],"prefix":"10.2478","volume":"12","author":[{"given":"Amer","family":"Farooqi","sequence":"first","affiliation":[{"name":"SKMCH&RC: Shaukat Khanum Memorial Cancer Hospital and Research Centre , Peshawar , KPK PAKISTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshed","family":"Ali","sequence":"additional","affiliation":[{"name":"SKMCH&RC: Shaukat Khanum Memorial Cancer Hospital and Research Centre , Peshawar , KPK PAKISTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Sajjad","sequence":"additional","affiliation":[{"name":"SKMCH&RC: Shaukat Khanum Memorial Cancer Hospital and Research Centre , Peshawar , KPK PAKISTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Ullah","sequence":"additional","affiliation":[{"name":"SKMCH&RC: Shaukat Khanum Memorial Cancer Hospital and Research Centre , Peshawar , KPK PAKISTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2026091908311050070_j_jcas-2026-0009_ref_001","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May;74(3):229\u201363.","DOI":"10.3322\/caac.21834"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_002","unstructured":"World Health Organization. Palliative Care: NCC Clin Pract Guidel Oncol [Internet]. Geneva: WHO; 2020 [cited 2025 Oct 31]. Version 1.2020 \u2014 February 7, 2020. p. 68\u20139."},{"key":"2026091908311050070_j_jcas-2026-0009_ref_003","doi-asserted-by":"crossref","unstructured":"Punjwani R, Khatoon A, Dias JM, Kurji ZA, Siddiqui DF, Bana S, Baig-Ansari N. Palliative care in nursing: where are we in Pakistan. J Palliat Care Med. 2015;5:002.","DOI":"10.4172\/2165-7386.1000S5002"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_004","doi-asserted-by":"crossref","unstructured":"Wright M, Wood J, Lynch T, Clark D. Mapping levels of palliative care development: a global view. J Pain Symptom Manage. 2008 May;35(5):469\u201385.","DOI":"10.1016\/j.jpainsymman.2007.06.006"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_005","unstructured":"World Health Organization. Globocan 2020 Pakistan report. Glob Cancer Obs. 2021;928:2020\u20131."},{"key":"2026091908311050070_j_jcas-2026-0009_ref_006","doi-asserted-by":"crossref","unstructured":"Cripe LD, Frankel RM. Dying from cancer: communication, empathy, and the clinical imagination. J Patient Exp. 2017 Jun;4(2): 69\u201373.","DOI":"10.1177\/2374373517699443"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_007","doi-asserted-by":"crossref","unstructured":"Engeser P, Glassman J, Leutgeb R, Szecsenyi J, Laux G. Early integration of palliative care for outpatients with advanced cancer in general practice: how is the situation?\u2014a cohort study. Ann Palliat Med. 2021 Mar;10(3):2843848\u20132848.","DOI":"10.21037\/apm-20-2377"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_008","doi-asserted-by":"crossref","unstructured":"Sep\u00falveda C, Marlin A, Yoshida T, Ullrich A. Palliative care: the World Health Organization\u2019s global perspective. J Pain Symptom Manage. 2002 Aug;24(2):91\u20136.","DOI":"10.1016\/S0885-3924(02)00440-2"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_009","doi-asserted-by":"crossref","unstructured":"Sanders JJ, Temin S, Ghoshal A, Alesi ER, Ali ZV, Chauhan C, Cleary JF, Epstein AS, Firn JI, Jones JA, Litzow MR. Palliative care for patients with cancer: ASCO guideline update. J Clin Oncol. 2024 May;JCO-24.","DOI":"10.1200\/JCO.24.00542"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_010","doi-asserted-by":"crossref","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell [Internet]. 2000 Jan 7 [cited 2023 Nov 18];100(1):57\u201370. Avail","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_011","doi-asserted-by":"crossref","unstructured":"Lammers A, Slatore CG, Fromme EK, Vranas KC, Sullivan DR. Association of early palliative care with chemotherapy intensity in patients with advanced stage lung cancer: a national cohort study. J Thorac Oncol. 2019 Feb 1;14(2):176\u201383.","DOI":"10.1016\/j.jtho.2018.09.029"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_012","doi-asserted-by":"crossref","unstructured":"Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991 Jun;7(2):6\u20139.","DOI":"10.1177\/082585979100700202"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_013","doi-asserted-by":"crossref","unstructured":"Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35(1):96\u2013112.","DOI":"10.1200\/JCO.2016.70.1474"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_014","doi-asserted-by":"crossref","unstructured":"Hui D, Bansal S, Strasser F, Morita T, Caraceni A, Davis M, et al. Indicators of integration of oncology and palliative care programs: an international consensus. Ann Oncol [Internet]. 2015 Sep 1 [cited 2023 Nov 18];26(9):1953\u20139.","DOI":"10.1093\/annonc\/mdv269"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_015","doi-asserted-by":"crossref","unstructured":"El-Jawahri A, LeBlanc TW, Kavanaugh A, Webb JA, Jackson VA, Campbell TC, et al. Effectiveness of integrated palliative and oncology care for patients with acute myeloid leukemia: a randomized clinical trial. JAMA Oncol. 2021 Feb 1;7(2):238\u201345.","DOI":"10.1001\/jamaoncol.2020.6343"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_016","doi-asserted-by":"crossref","unstructured":"El-Jawahri A, Greer JA, Pirl WF, Park ER, Jackson VA, Back AL, et al. Effects of early integrated palliative care on caregivers of patients with lung and gastrointestinal cancer: a randomized clinical trial. Oncologist. 2017 Dec 1;22(12):1528\u201334.","DOI":"10.1634\/theoncologist.2017-0227"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_017","doi-asserted-by":"crossref","unstructured":"Baena-Ca\u00f1ada JM, Campini Bermejo A, Gamez Casado S, Rodriguez Perez L, Quilez Cutillas A, Calvete Candenas J, et al. Experiences with prescribing large quantities of systemic anticancer therapy near death. J Palliat Med. 2019 Dec 1;22(12):1515\u201321.","DOI":"10.1089\/jpm.2019.0017"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_018","doi-asserted-by":"crossref","unstructured":"Bao Y, Maciejewski RC, Garrido MM, Shah MA, Maciejewski PK, Prigerson HG. Chemotherapy use, end-of-life care, and costs of care among patients diagnosed with stage IV pancreatic cancer. J Pain Symptom Manage. 2018 Apr 1;55(4):1113\u201321.","DOI":"10.1016\/j.jpainsymman.2017.12.335"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_019","doi-asserted-by":"crossref","unstructured":"Earle CC, Neville BA, Landrum MB, Souza JM, Weeks JC, Block SD, et al. Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care. 2005 Dec 1;17(6):505\u20139.","DOI":"10.1093\/intqhc\/mzi061"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_020","doi-asserted-by":"crossref","unstructured":"Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003 Mar 15;21(6):1133\u20138.","DOI":"10.1200\/JCO.2003.03.059"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_021","doi-asserted-by":"crossref","unstructured":"Rochigneux P, Raoul JL, Beaussant Y, Aubry R, Goldwasser F, Tournigand C, et al. Use of chemotherapy near the end of life: what factors matter? Ann Oncol [Internet]. 2017 Apr 1 [cited 2023 Nov 18];28(4):809\u201317.","DOI":"10.1093\/annonc\/mdw654"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_022","doi-asserted-by":"crossref","unstructured":"Bandieri E, Banchelli F, Artioli F, Mucciarini C, Razzini G, Cruciani M, et al. Early versus delayed palliative\/supportive care in advanced cancer: an observational study. BMJ Support Palliat Care. 2020;10(4):e32.","DOI":"10.1136\/bmjspcare-2019-001794"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_023","doi-asserted-by":"crossref","unstructured":"Keam B, Kim J, Hong Y, Lee S, Kim D, Im S, et al. Aggressiveness of cancer care near the end of life. J Clin Oncol [Internet]. 2006 Jun 20 [cited 2024 Dec 15];24(18_suppl):6103.","DOI":"10.1200\/jco.2006.24.18_suppl.6103"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_024","doi-asserted-by":"crossref","unstructured":"Kress MAS, Jensen RE, Tsai HT, Lobo T, Satinsky A, Potosky AL. Radiation therapy at the end of life: a population-based study examining palliative treatment intensity. Radiat Oncol. 2015;10(1): 1\u20139.","DOI":"10.1186\/s13014-014-0305-4"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_025","doi-asserted-by":"crossref","unstructured":"Gomes B, Calanzani N, Gysels M, Hall S, Higginson IJ. Heterogeneity and changes in preferences for dying at home: a systematic review. BMC Palliat Care [Internet]. 2013 Feb 15 [cited 2023 Nov 19];12(1):1\u201313.","DOI":"10.1186\/1472-684X-12-7"},{"key":"2026091908311050070_j_jcas-2026-0009_ref_026","doi-asserted-by":"crossref","unstructured":"Townsend J, Frank AO, Fermont D, Dyer S, Karran O, Walgrove A, et al. Terminal cancer care and patients\u2019 preference for place of death: a prospective study. BMJ. 1990;301(6749):415\u20137.","DOI":"10.1136\/bmj.301.6749.415"}],"container-title":["Journal of Cancer and Allied Specialties"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/jcas-2026-0009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:31:28Z","timestamp":1789806688000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/jcas-2026-0009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,29]]},"published-print":{"date-parts":[[2026,3,1]]}},"alternative-id":["10.2478\/jcas-2026-0009"],"URL":"https:\/\/doi.org\/10.2478\/jcas-2026-0009","relation":{},"ISSN":["2411-989X"],"issn-type":[{"value":"2411-989X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}